Literature DB >> 24444375

Bunina bodies in motor and non-motor neurons revisited: a pathological study of an ALS patient after long-term survival on a respirator.

Tadashi Kimura1, Haishan Jiang, Takuya Konno, Makiko Seto, Keisuke Iwanaga, Mitsuhiro Tsujihata, Akira Satoh, Osamu Onodera, Akiyoshi Kakita, Hitoshi Takahashi.   

Abstract

Bunina bodies (BBs) are small eosinophilic neuronal cytoplasmic inclusions (NCIs) found in the remaining lower motor neurons (LMNs) of patients with sporadic amyotrophic lateral sclerosis (SALS), being a specific feature of the cellular pathology. We examined a case of SALS, unassociated with TDP-43 or C9ORF72 mutation, of 12 years duration in a 75-year-old man, who had received artificial respiratory support for 9 years, and showed widespread multisystem degeneration with TDP-43 pathology. Interestingly, in this patient, many NCIs reminiscent of BBs were observed in the oculomotor nucleus, medullary reticular formation and cerebellar dentate nucleus. As BBs in the cerebellar dentate nucleus have not been previously described, we performed ultrastructural and immunohistochemical studies of these NCIs to gain further insight into the nature of BBs. In each region, the ultrastructural features of these NCIs were shown to be identical to those of BBs previously described in LMNs. These three regions and the relatively well preserved sacral anterior horns (S1 and S2) and facial motor nucleus were immunostained with antibodies against cystatin C (CC) and TDP-43. Importantly, it was revealed that BBs exhibiting immunoreactivity for CC were a feature of LMNs, but not of non-motor neurons, and that in the cerebellar dentate nucleus, the ratio of neurons with BBs and TDP-43 inclusions/neurons with BBs was significantly lower than in other regions. These findings suggest that the occurrence of BBs with CC immunoreactivity is intrinsically associated with the particular cellular properties of LMNs, and that the mechanism responsible for the formation of BBs is distinct from that for TDP-43 inclusions.
© 2014 Japanese Society of Neuropathology.

Entities:  

Keywords:  Bunina body; TDP-43; amyotrophic lateral sclerosis; cystatin C; non-motor neuron

Mesh:

Year:  2014        PMID: 24444375     DOI: 10.1111/neup.12105

Source DB:  PubMed          Journal:  Neuropathology        ISSN: 0919-6544            Impact factor:   1.906


  9 in total

1.  TDP-43 pathology and neuronal loss in amyotrophic lateral sclerosis spinal cord.

Authors:  Johannes Brettschneider; Kimihito Arai; Kelly Del Tredici; Jon B Toledo; John L Robinson; Edward B Lee; Satoshi Kuwabara; Kazumoto Shibuya; David J Irwin; Lubin Fang; Vivianna M Van Deerlin; Lauren Elman; Leo McCluskey; Albert C Ludolph; Virginia M-Y Lee; Heiko Braak; John Q Trojanowski
Journal:  Acta Neuropathol       Date:  2014-06-12       Impact factor: 17.088

Review 2.  Pathophysiology and Treatment of Non-motor Dysfunction in Amyotrophic Lateral Sclerosis.

Authors:  Colin J Mahoney; Rebekah M Ahmed; William Huynh; Sicong Tu; Jonathan D Rohrer; Richard S Bedlack; Orla Hardiman; Matthew C Kiernan
Journal:  CNS Drugs       Date:  2021-05-15       Impact factor: 5.749

3.  Vascular Endothelial Growth Factor (VEGF) Prevents the Downregulation of the Cholinergic Phenotype in Axotomized Motoneurons of the Adult Rat.

Authors:  Lourdes Acosta; Sara Morcuende; Silvia Silva-Hucha; Angel M Pastor; Rosa R de la Cruz
Journal:  Front Mol Neurosci       Date:  2018-07-12       Impact factor: 5.639

Review 4.  Involvement of cystatin C in immunity and apoptosis.

Authors:  Mengting Zi; Yuekang Xu
Journal:  Immunol Lett       Date:  2018-01-31       Impact factor: 3.685

Review 5.  Cystatin C is a disease-associated protein subject to multiple regulation.

Authors:  Yuekang Xu; Ying Ding; Xinchen Li; Xiaobing Wu
Journal:  Immunol Cell Biol       Date:  2015-02-03       Impact factor: 5.126

6.  Serum Cystatin C and Coronavirus Disease 2019: A Potential Inflammatory Biomarker in Predicting Critical Illness and Mortality for Adult Patients.

Authors:  Dan Chen; Wenwu Sun; Jia Li; Bohua Wei; Wei Liu; Xiaopin Wang; Fan Song; Liangkai Chen; Junhui Yang; Li Yu
Journal:  Mediators Inflamm       Date:  2020-10-08       Impact factor: 4.711

7.  Clinicopathological characteristics of patients with amyotrophic lateral sclerosis resulting in a totally locked-in state (communication Stage V).

Authors:  Kentaro Hayashi; Yoko Mochizuki; Ryoko Takeuchi; Toshio Shimizu; Masahiro Nagao; Kazuhiko Watabe; Nobutaka Arai; Kiyomitsu Oyanagi; Osamu Onodera; Masaharu Hayashi; Hitoshi Takahashi; Akiyoshi Kakita; Eiji Isozaki
Journal:  Acta Neuropathol Commun       Date:  2016-09-30       Impact factor: 7.801

8.  Dominant Heterogeneity of Upper and Lower Motor Neuron Degeneration to Motor Manifestation of Involved Region in Amyotrophic Lateral Sclerosis.

Authors:  Jiaoting Jin; Fangfang Hu; Qiuli Zhang; Qiaoyi Chen; Haining Li; Xing Qin; Rui Jia; Li Kang; Yonghui Dang; Jingxia Dang
Journal:  Sci Rep       Date:  2019-12-27       Impact factor: 4.379

Review 9.  Protein Homeostasis in Amyotrophic Lateral Sclerosis: Therapeutic Opportunities?

Authors:  Christopher P Webster; Emma F Smith; Pamela J Shaw; Kurt J De Vos
Journal:  Front Mol Neurosci       Date:  2017-05-02       Impact factor: 5.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.